Abstract
37% (57/155) of sera from patients with rheumatoid arthritis contain cold-reacting lymphocytotoxic antibodies. Lymphocytotoxins were predominantly of the weakly reactive type and were more likely to be present in patients who were HLA-DR4 positive. By contrast, patients who were HLA-DR3 positive were more likely to have strongly reactive lymphocytotoxins. The lymphocyte subclass reactivity of the lymphocytotoxins was: 67% versus B lymphocytes, 27% against both T and B cells, and 7% for T cells.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Browning J. D., Dick H. M., El-Ghobarey A., Dick W. C. Levamisole, rheumatoid arthritis, and cold lymphocytotoxic antibodies. Lancet. 1977 Oct 15;2(8042):820–820. doi: 10.1016/s0140-6736(77)90752-8. [DOI] [PubMed] [Google Scholar]
- Koike T., Kobayashi S., Yoshiki T., Itoh T., Shirai T. Differential sensitivity of functional subsets of T cells to the cytotoxicity of natural T-lymphocytotoxic autoantibody of systemic lupus erythematosus. Arthritis Rheum. 1979 Feb;22(2):123–129. doi: 10.1002/art.1780220204. [DOI] [PubMed] [Google Scholar]
- Kreisler M. J., Hirata A. A., Terasaki P. I. Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation. 1970 Nov;10(5):411–415. [PubMed] [Google Scholar]
- Mittal K. K., Rossen R. D., Sharp J. T., Lidsky M. D., Butler W. T. Lymphocyte cytotoxic antibodies in systemic lupus erythematosus. Nature. 1970 Mar 28;225(5239):1255–1256. doi: 10.1038/2251255a0. [DOI] [PubMed] [Google Scholar]
- Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steffen C., Thumb N., Frank O., Eberl R., Tausch G., Boros M. Demonstration of lymphocytotoxins in rheumatoid arthritis in comparison with clinical course and other antibody activities. Z Immunitatsforsch Exp Klin Immunol. 1973 Jun;145(4):303–311. [PubMed] [Google Scholar]
- Strelkauskas A. J., Callery R. T., McDowell J., Borel Y., Schlossman S. F. Direct evidence for loss of human suppressor cells during active autoimmune disease. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5150–5154. doi: 10.1073/pnas.75.10.5150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Terasaki P. I., Mottironi V. D., Barnett E. V. Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med. 1970 Oct 1;283(14):724–728. doi: 10.1056/NEJM197010012831403. [DOI] [PubMed] [Google Scholar]
- Zilko P. J., Dawkins R. L., Holmes K., Witt C. Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol. 1979 Oct;14(2):222–230. doi: 10.1016/0090-1229(79)90143-0. [DOI] [PubMed] [Google Scholar]